Platelet-activating/JJ
factor/NN
induces/VBZ
phospholipid/JJ
turnover/NN
,/,
calcium/NN
flux/NN
,/,
arachidonic/JJ
acid/NN
liberation/NN
,/,
eicosanoid/NN
generation/NN
,/,
and/CC
oncogene/JJ
expression/NN
in/IN
a/DT
human/JJ
B/NN
cell/NN
line/NN
./.

Platelet-activating/JJ
factor/NN
is/VBZ
a/DT
potent/JJ
mediator/NN
of/IN
the/DT
inflammatory/JJ
response/NN
./.
=====
Studies/NNS
of/IN
the/DT
actions/NNS
of/IN
platelet-activating/JJ
factor/NN
have/VBP
centered/VBN
mainly/RB
around/IN
neutrophils/NNS
,/,
monocytes/NNS
,/,
and/CC
platelets/NNS
./.
=====
In/IN
this/DT
report/NN
we/PRP
begin/VBP
to/TO
uncover/VB
the/DT
influence/NN
of/IN
platelet-activating/NN
factor/NN
on/IN
B/NN
lymphocytes/NNS
./.
=====
Employing/VBG
the/DT
EBV-transformed/JJ
human/JJ
B/NN
cell/NN
line/NN
SKW6.4/NN
,/,
we/PRP
demonstrate/VBP
that/IN
platelet-activating/JJ
factor/NN
significantly/RB
alters/VBZ
membrane/NN
phospholipid/JJ
metabolism/NN
indicated/VBN
by/IN
the/DT
incorporation/NN
of/IN
32P/NN
into/IN
phosphatidylcholine/NN
,/,
phosphatidylinositol/NN
,/,
and/CC
phosphatidic/JJ
acid/NN
but/CC
not/RB
significantly/RB
into/IN
phosphatidylethanolamine/NN
at/IN
concentrations/NNS
ranging/VBG
from/IN
10/CD
(/(
-9/CD
)/)
to/TO
10/CD
(/(
-6/CD
)/)
M/NN
./.
=====
The/DT
inactive/JJ
precursor/NN
,/,
lyso-platelet-activating/JJ
factor/NN
,/,
at/IN
a/DT
concentration/NN
as/RB
high/JJ
as/IN
10/CD
(/(
-7/CD
)/)
M/NN
had/VBD
no/DT
effect/NN
on/IN
any/DT
of/IN
the/DT
membrane/NN
phospholipids/NNS
./.
=====
We/PRP
also/RB
show/VBP
that/IN
platelet-activating/JJ
factor/NN
from/IN
10/CD
(/(
-12/CD
)/)
to/TO
10/CD
(/(
-6/CD
)/)
M/NN
induced/VBD
rapid/JJ
and/CC
significant/JJ
elevation/NN
in/IN
intracellular/JJ
calcium/NN
levels/NNS
,/,
whereas/IN
lyso-platelet-activating/JJ
factor/NN
was/VBD
again/RB
ineffective/JJ
./.
=====
We/PRP
further/RB
demonstrate/VBP
the/DT
impact/NN
of/IN
platelet-activating/JJ
factor/NN
binding/VBG
to/TO
B/NN
cells/NNS
by/IN
measuring/VBG
platelet-activating/JJ
factor/NN
induced/JJ
arachidonic/JJ
acid/NN
release/NN
and/CC
5-hydroxyeicosatetraenoic/JJ
acid/NN
production/NN
./.
=====
Moreover/RB
,/,
platelet-activating/JJ
factor/NN
was/VBD
capable/JJ
of/IN
inducing/VBG
transcription/NN
of/IN
the/DT
nuclear/JJ
proto-oncogenes/NNS
c-fos/NN
and/CC
c-jun/NN
./.
=====
Finally/RB
we/PRP
explored/VBD
the/DT
possible/JJ
role/NN
of/IN
5-hydroxyeicosatetraenoic/JJ
acid/NN
as/IN
a/DT
regulator/NN
of/IN
arachidonic/JJ
acid/NN
liberation/NN
demonstrating/VBG
that/IN
endogenous/JJ
5-lipoxygenase/NN
activity/NN
modulates/VBZ
platelet-activating/JJ
factor/NN
induced/JJ
arachidonic/JJ
acid/NN
release/NN
perhaps/RB
acting/VBG
at/IN
the/DT
level/NN
of/IN
phospholipase/NN
A2/NN
./.
=====
In/IN
summary/NN
,/,
platelet-activating/JJ
factor/NN
is/VBZ
shown/VBN
here/RB
to/TO
have/VB
a/DT
direct/JJ
and/CC
profound/JJ
effect/NN
on/IN
a/DT
pure/JJ
B/NN
cell/NN
line/NN
./.